ArcticZymes Technologies - Board/Management Information 2024

ArcticZymes Technologies Announces Nomination of Dr. Frank Mathias as Chairman of the Board

Tromsø, Norway - June 25, 2024 - ArcticZymes Technologies (OSE:AZT) is pleased

to announce the nomination of Dr. Frank Mathias as the new Chairman of the

Board.

Dr. Mathias is the CEO at Oxford Biomedica, a leading pure-play CDMO within the

cell and gene therapy industry. Dr. Mathias was previously the CEO of Rentschler

Biopharma SE, which he successfully developed into a leading global, full

-service CDMO. Prior to Rentschler, Dr. Mathias served as CEO of Medigene AG, a

publicly listed immuno-oncology company. During his 30-year career, Dr. Mathias

has held senior roles at leading global pharmaceutical companies, including

Amgen Deutschland GmbH, Servier Deutschland GmbH, and Hoechst AG. In 2019, he

was awarded the "EY Entrepreneur of the Year" title in Germany. Dr. Mathias is a

pharmacist by training and completed his Doctorate in Pharmacy at Paris VI

University.

"We are very pleased to nominate Frank Mathias as our new Chairman of the

Board," said Jon R. Sandberg, Chairman of the Nomination Committee. "Frank

Mathias' extensive experience and visionary leadership make him the ideal

candidate to guide our company into its next phase of development,

commercialization and growth."

"I am honoured to join ArcticZymes at such a pivotal time," said Dr. Frank

Mathias. "The innovative enzyme solutions developed by ArcticZymes have made

significant contributions to advancements in biomanufacturing, enhancing

efficiency and quality across the industry. I look forward to contributing to

the company's continued success and collaborative growth."

For more information, please contact:

ArcticZymes Technologies ASA

CEO, Michael B. Akoh Tel: +46 (0) 70 262 37 15

About ArcticZymes Technologies ASA:

ArcticZymes Technologies ASA (OSE: AZT) is a global leader in supplying best-in

-class enzyme technologies to commercial partners who develop therapeutics, in

vitro diagnostics, and molecular research kit products. Our mission is to make

our customers lives easier by unlocking new solutions to enhance quality of life

and create a more sustainable healthy world.

AI assistant